Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:12
December, 2004
Dear Readers,
In this month’s Evidence Corner, Dr. Laura Bolton reviews and comments on two articles addressing variables that affect spinal-cord injury outcomes. The first article by Bagnall, et al., assessed the benefits and shortcomings of spinal fixation, referral to a spinal-injury unit (SIU), and steroid treatment. It would appear that early referral to a SIU is an important consideration for these patients. The second article by Hicks, et al., is a report of a prospective, randomized, controlled study on the effects of a nine-month course of exercise on patient s
- Issue:12
D ear readers: We dedicate this month’s Evidence Corner to Christopher Reeve, who died October 10, 2004, following a pressure-ulcer-related systemic infection that caused cardiac arrest.1 May his life and work continue to help those with spinal-cord injuries around the world. According to growing evidence, not all from controlled studies, patient and physician decisions made both early and late after spinal-cord injury may affect recovery. A 2004 Cochrane review2 concluded that there were no randomized, controlled trials addressing the benefits or disadvantages of immediate versus late refe
- Issue:12
Presentation
A 25-year-old African American woman with a four-year history of dermatomyositis (DM) presented with an ulcer in the right popliteal fossa of five weeks duration. Initially, the patient was diagnosed with DM based on typical heliotrope rash, photosensitivity, high creatinine kinase (CK), and interstitial lung disease. Her serology for other connective tissue diseases was negative. She was initially treated with oral prednisone 1mg/Kg/d. After normalization of CK levels, prednisone was tapered to 10mg/d but never discontinued. Two years later, she developed calcium deposits on
- The Effect of 810 Nanometer Diode Laser Irradiation on Healing of Full-Thickness Skin Wounds in RatsIssue:12
T hroughout history, there have been many advances made in wound management. Research on new modalities to enhance wound healing is ongoing at most medical centers. One such modality is laser irradiation.
Laser irradiation as a phototherapeutic means for the stimulation and/or acceleration of wound healing began in the 1970s by Mester and colleagues.1,2 Since then, approximately 2,000 studies have been published, producing a wide range of results. Despite extensive research, controversy as to the effects of the laser on wound healing remains.3,4 This controversy is in p - Issue:12
C hronic wounds are caused by a variety of etiologies, including diabetic neuropathy, venous and/or arterial insufficiency, and prolonged pressure.1 In addition to significant morbidity and both financial and emotional costs, chronic wounds have been associated with an increased risk of osteomyelitis and limb amputation and increased mortality.2 At present, despite addressing the underlying pathophysiology of the wound and employing adjuvant therapies, such as growth factors and tissue-engineered skin, a need exists for additional options in the therapeutic arsenal. In t
- Issue:12
Healthpoint Signs Distribution Agreement to Launch OASIS® Wound Matrix and OASIS® Burn Matrix in Central America
Healthpoint®, Ltd., has signed an agreement with Costa Rica-based Elcom to market and sell OASIS® Wound Matrix and OASIS® Burn Matrix. OASIS is a biomaterial that can be used in the management of partial- and full-thickness skin loss injuries, such as pressure, venous, and chronic vascular ulcers, diabetic ulcers, surgical and trauma wounds, second-degree burns, abrasions, and autograft donor sites.
The agreement grants Elcom exclusive distribution rights for OASIS produ
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |








